Insomnia and Sleep Health with Integrative Chiropractic Care

Transform your sleep with integrative chiropractic care for insomnia. Discover natural techniques for improved rest and relaxation.

Navigating the Labyrinth of Insomnia: An Integrative Approach to Restful Sleep

Hello, I’m Dr. Alex Jimenez. Welcome to our educational series where we explore complex health topics through the lens of integrative and functional medicine. My healthcare journey has been multifaceted, driven by a passion for understanding the intricate connections within the human body. As a Doctor of Chiropractic (DC), I began by focusing on the neuromusculoskeletal system. However, my clinical observations consistently pointed toward a deeper truth: optimal health requires a holistic approach. This led me to further my education, becoming an Advanced Practice Registered Nurse (APRN) and a Board-Certified Family Nurse Practitioner (FNP-BC). This dual licensure allows me to bridge the gap between structural alignment and systemic medical care. My quest for knowledge didn’t stop there. I pursued advanced certifications as a Certified Functional Medicine Practitioner (CFMP), an Institute for Functional Medicine Certified Practitioner (IFMCP), an Autoimmune Triple Negative (ATN) specialist, and a Certified Clinical Shiatsu Therapist (CCST). These credentials represent my commitment to a comprehensive, patient-centered model of care that seeks to identify and address the root causes of disease.

Today, we’re delving into a widespread yet often misunderstood condition: insomnia. In this educational post, I am honored to share this material with you, drawing upon my extensive background to explore the vital topic of insomnia management, blending cutting-edge research with the principles of integrative and functional medicine.

Abstract: A Comprehensive Guide to Understanding and Managing Insomnia

This educational post provides a comprehensive exploration of insomnia, a prevalent and often chronic condition with significant impacts on mental and physiological health. From my perspective as a practitioner with a diverse background in chiropractic, nursing, and functional medicine, I will guide you through the complexities of this condition in an easy-to-understand way. We will begin by examining the intricate neurophysiology of sleep, including the roles of the circadian rhythm, adenosine, and the revolutionary glymphatic system. The post highlights the far-reaching consequences of untreated insomnia, from cognitive and motor impairments to disruptions in our immune, metabolic, and hormonal systems. We will discuss its role as a risk factor for psychiatric disorders, neurodegenerative diseases like Alzheimer’s, and diminished quality of life.

This post will serve as your guide to understanding the importance of regular sleep assessment, utilizing tools like the Insomnia Severity Index and sleep diaries. We will then detail a holistic and individualized assessment approach, emphasizing the importance of a thorough patient history and diagnostic evaluation. A central theme is integrating various evidence-based treatment strategies within a multidisciplinary care model. We will delve into a multimodal treatment strategy, emphasizing the gold-standard Cognitive Behavioral Therapy for Insomnia (CBTI) and its principles of sleep restriction and cognitive restructuring. Furthermore, we will explore the critical role of sleep hygiene, relaxation techniques, and the judicious use of hypnotic medications, detailing their mechanisms of action, benefits, and significant risks associated with various classes, including benzodiazepines, “Z-drugs,” melatonin receptor agonists, orexin receptor antagonists, and antidepressants. We will also discuss the limitations of popular over-the-counter supplements like valerian root, passionflower, and chamomile, highlighting the need for more robust research.

To bring these concepts to life, we will explore two detailed case studies: one involving a 57-year-old male with a history of addiction, and another concerning a 70-year-old female with multiple comorbidities, including cognitive impairment. These examples illustrate the critical importance of a personalized, patient-centered approach to treatment. A key focus will be the integrative care model we employ at Injury Medical Clinic, where medical oversight from Dr. Maria Cardenas, MD, is combined with my expertise in chiropractic and functional medicine. The post emphasizes the principles of shared decision-making, individualizing treatment based on patient characteristics, and prioritizing safety, especially in vulnerable populations. Finally, we will address strategies for managing treatment-resistant insomnia, advocating for an interprofessional, collaborative approach as the gold standard for achieving positive, long-term outcomes. My goal is to empower you with the knowledge to reclaim restorative sleep and enhance your quality of life.

Our Integrative Team: A Fusion of Medical and Chiropractic Expertise

Here at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic), located in El Paso, Texas, we have built a unique, multidisciplinary practice founded on the principles of integrative and collaborative care. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, who serves as our Medical Director and Collaborative Physician. Dr. Cardenas is a highly respected, board-certified Internist with a Texas medical license (#J2933) and an NPI number of 1164426749. With over four decades of clinical experience, she brings an incredible depth of medical knowledge and diagnostic acumen to our practice. Her extensive medical knowledge and compassionate approach provide the essential medical oversight that anchors our practice. Her role is not just supervisory; it is deeply collaborative. She provides essential medical direction and oversight, ensuring that every patient receives care that is effective, medically sound, and safe. Our collaborative model is common in advanced injury and integrative care settings, where the expertise of a medical doctor and a chiropractor are combined to offer patients the most thorough and effective treatment plans.

This partnership between a Doctor of Chiropractic (DC) and a Medical Doctor (MD) is a cornerstone of modern integrative health. Together, Dr. Cardenas and our team of dedicated health professionals integrate chiropractic care, internal medicine, functional medicine, personal injury rehabilitation, physical therapy, and nutritional counseling. Here’s how our synergy benefits you:

• Comprehensive Diagnosis: When a patient presents with a condition like chronic insomnia, my functional medicine and chiropractic evaluation focuses on biomechanical, neurological, and lifestyle factors. Simultaneously, Dr. Cardenas provides a thorough medical assessment, ruling out or managing underlying organic diseases such as cardiovascular conditions, kidney disease, or hormonal imbalances that could be contributing to sleep disturbances.
• Integrated Treatment Plans: Our treatment plans are a fusion of our respective disciplines. For a patient with insomnia and chronic back pain, for instance, I would implement chiropractic adjustments to address spinal misalignments and reduce nerve irritation, which can be a significant source of sleep-disrupting pain. At the same time, Dr. Cardenas would manage the patient’s medical needs, perhaps adjusting medications that might interfere with sleep or prescribing appropriate medical interventions if a condition like sleep apnea is suspected.
• Holistic and Functional Approach: Together, we embrace a functional medicine framework. We look beyond symptoms to identify the root causes of your health issues. This involves advanced diagnostic testing to assess nutritional deficiencies, gut microbiome health, hormonal imbalances, and inflammatory markers—all of which are intricately linked to sleep quality.
• Safe and Coordinated Care: The collaboration ensures a safety net for our patients. All treatment protocols, from chiropractic rehabilitation and nutritional recommendations to any medical prescriptions, are reviewed and coordinated between Dr. Cardenas and me. This prevents conflicting treatments and ensures all aspects of your health are considered.

Our practice is a testament to the power of breaking down professional silos. By integrating these various modalities, we offer a patient-centered experience that addresses the whole person, not just an isolated symptom. This allows us to create truly personalized care strategies that address not just the symptoms but the entire person—mind, body, and spirit. This journey toward better sleep is one we walk with you, guided by the combined expertise of our dedicated team. In this post, we will apply this integrative framework to understand and manage insomnia, moving beyond simple sleep aids to explore the underlying physiological, environmental, and emotional factors that disrupt our natural sleep cycles.

Understanding the Modern Epidemic of Sleeplessness

Insomnia is an incredibly common condition in our modern world, and for many, it becomes a chronic, debilitating issue. Current research estimates that a staggering 20% to 50% of all patients visiting primary care clinics suffer from chronic insomnia. This isn’t a fleeting problem; it’s a persistent challenge that has risen sharply in recent decades. Much of this increase can be directly linked to our contemporary lifestyle. We spend unprecedented amounts of time bathed in the blue light of screens—from our phones and tablets to our televisions and computers—and surrounded by bright, artificial lighting that extends our “day” long after the sun has set. These environmental factors actively suppress the body’s natural sleep signals, disrupting the delicate biological symphony that orchestrates restful sleep.

Despite its prevalence, insomnia remains a condition that is frequently under-recognized and, consequently, undertreated in clinical settings. Studies reveal a significant communication gap: only about a quarter to a half of patients ever mention their sleep difficulties to their primary care provider. Even more concerning, nearly three-quarters of patients report that their provider did not even ask about their sleep quality during their most recent visit. This oversight is a critical missed opportunity for intervention.

It is crucial to recognize that insomnia is not a one-size-fits-all diagnosis. The experience of sleeplessness can manifest in vastly different ways from one individual to the next. Some people struggle with sleep-onset insomnia, where the primary difficulty is falling asleep at the beginning of the night. Others experience sleep-maintenance insomnia, where they can fall asleep easily but wake up multiple times throughout the night and struggle to get back to sleep. A third common presentation is early-morning awakening, where an individual wakes up far earlier than intended and cannot resume sleeping, effectively cutting their total sleep time short. Often, patients experience a combination of these patterns, further complicating their condition.

Just as the presentation of insomnia varies, so do our individual sleep needs. The amount of sleep required for optimal health and functioning changes significantly across the lifespan.

• School-Aged Children and Adolescents: These age groups require a substantial amount of sleep to support their rapid physical, cognitive, and emotional development. The recommended range is typically 9 to 10 hours per night.
• Adults: For most adults, the sweet spot for restorative sleep lies between 7 and 9 hours per night. Consistently falling outside this range, in either direction, has been linked to adverse health outcomes.

Understanding these fundamentals is the first step toward appreciating the complexity of insomnia and the importance of a personalized approach to its assessment and management.

Identifying the Key Risk Factors for Insomnia

Through extensive research, we have identified several key demographic and clinical factors that significantly increase an individual’s vulnerability to developing insomnia. Recognizing these risk factors is essential for both prevention and targeted intervention.

• Older Age: This is perhaps one of the most significant risk factors. As we age, our natural sleep architecture changes. We tend to experience less deep, restorative sleep and more frequent awakenings. These physiological shifts, combined with a higher prevalence of chronic medical conditions and medication use, make older adults particularly susceptible to sleep problems.
• Female Sex: Women are more likely than men to report insomnia. This disparity is often linked to hormonal fluctuations throughout the lifespan, particularly during the perimenopausal and postmenopausal periods, when changes in estrogen and progesterone can profoundly disrupt sleep patterns.
• Veterans and Active-Duty Military Personnel: This population faces a unique combination of stressors, including deployment, combat exposure, irregular schedules, and a higher incidence of traumatic brain injuries (TBI) and post-traumatic stress disorder (PTSD), all of which are strongly correlated with chronic insomnia.
• Lower Socioeconomic Status and Homelessness: Individuals facing financial hardship, housing instability, and food insecurity experience chronic stress and often live in environments that are not conducive to sleep (e.g., noisy, unsafe neighborhoods). This constant state of hypervigilance and stress severely disrupts the sleep-wake cycle.
• Poor Overall Health and Multiple Comorbidities: Chronic diseases, such as cardiovascular disease, diabetes, chronic pain conditions (like fibromyalgia or arthritis), and respiratory disorders (like sleep apnea), can directly interfere with sleep through pain, discomfort, or physiological disruption.
• Mental Health Conditions: There is a strong, bidirectional relationship between insomnia and mental illness. Conditions such as anxiety disorders, major depressive disorder, bipolar disorder, and ADHD are frequently accompanied by severe sleep disturbances. In many cases, insomnia can be both a symptom of the mental health condition and a factor that exacerbates it.
• History of Traumatic Brain Injury (TBI): A TBI can cause direct damage to the brain regions and neural networks that regulate sleep. The risk and severity of insomnia increase with the number of TBIs an individual has sustained.
• Alcohol Use Disorder: While alcohol is often mistakenly used as a sleep aid, chronic heavy alcohol use has devastating long-term effects on sleep architecture. It may initially induce drowsiness, but as it is metabolized, it leads to fragmented, non-restorative sleep, particularly by suppressing REM sleep. These disruptions can persist long after an individual has stopped drinking.

At Injury Medical Clinic, our integrative approach, overseen by Dr. Cardenas and me, necessitates a thorough evaluation of these risk factors. When a patient presents with chronic pain from a personal injury, for example, we don’t just focus on the site of injury. We assess for co-occurring issues like TBI, anxiety, and sleep disturbances, which are common in trauma survivors. Chiropractic adjustments can help alleviate musculoskeletal pain that disrupts sleep, while our functional medicine protocols can address underlying inflammation and nutritional deficiencies that contribute to both pain and insomnia. This comprehensive view is critical for effective, long-term recovery.

The Intricate Neurophysiology of Sleep

The process of falling asleep and staying asleep is a marvel of biological engineering, governed by a complex and still somewhat mysterious interplay of brain structures, neurotransmitters, and hormones. Understanding this neurophysiology is key to comprehending why sleep can be so easily disrupted and how different treatments work. Two primary processes govern our sleep: the circadian rhythm and sleep-wake homeostasis.

The Circadian Rhythm: Our Internal Master Clock

The circadian rhythm is the brain’s intrinsic 24-hour internal clock that orchestrates a wide range of physiological processes, including the cycle of sleepiness and alertness. The command center for this rhythm is a tiny region located in the hypothalamus called the suprachiasmatic nucleus (SCN). Often referred to as the “master clock” or “sleep pacemaker,” the SCN receives direct input from the eyes about the presence or absence of light.

• When light enters the eyes, it signals the SCN that it is daytime, prompting the release of alerting signals throughout the body.
• As light fades in the evening, the SCN triggers a cascade of events that prepare the body for sleep, most notably by signaling the pineal gland to begin producing melatonin, a hormone that promotes sleepiness.

Our modern lifestyle, with its constant exposure to artificial light, especially the blue-wavelength light from electronic devices, can profoundly disrupt this system. Exposure to blue light in the evening effectively tricks the SCN into thinking it is still daytime, suppressing melatonin production and delaying the onset of sleep.

Sleep-Wake Homeostasis: The Balancing Act

Running parallel to the circadian rhythm is the process of sleep-wake homeostasis, also known as the “sleep drive” or “sleep pressure.” The principle is simple: the longer you are awake, the greater your body’s physiological need for sleep becomes. The accumulation and clearance of specific neurochemicals in the brain regulate this drive.

One of the most important of these is adenosine. Adenosine is a byproduct of cellular energy consumption in the brain. Throughout the day, as our neurons are active, adenosine levels gradually build up in the spaces between brain cells. This accumulation has several key effects:

• It inhibits the activity of wakefulness-promoting neurons in key areas of the brain.
• It stimulates sleep-promoting neurons.
• It promotes vasodilation (relaxation of blood vessels) in the brain, which increases blood flow and contributes to the feeling of sleepiness.

The mechanism of caffeine provides a perfect illustration of this process. Caffeine is a potent adenosine receptor antagonist. It works by binding to the same receptors that adenosine would normally attach to, effectively blocking adenosine’s sleep-inducing signal from reaching the neurons. This is why caffeine promotes wakefulness and can interfere with sleep if consumed too late in the day.

During sleep, the brain works to clear this accumulated adenosine, reducing the sleep pressure. By morning, adenosine levels are at their lowest, and the cycle begins anew.

Another critical aspect of this homeostatic balance relates to cellular energy. The brain’s supportive cells, called astrocytes, store energy in the form of glycogen. During periods of wakefulness, these glycogen stores are depleted to fuel neural activity. Sleep is the essential period during which these glycogen stores are replenished, ensuring the brain has the energy it needs for the following day.

The Neurotransmitters of Wakefulness

While adenosine and melatonin promote sleep, a different set of neurotransmitters is responsible for maintaining wakefulness and alertness. Among the most important are histamine and orexin (also known as hypocretin).

• Histamine, widely known for its role in allergic reactions, also plays a crucial role in the brain as a promoter of arousal. This is why older antihistamine medications that can cross the blood-brain barrier (like diphenhydramine) cause significant drowsiness.
• Orexin is a neuropeptide produced in the hypothalamus that strongly promotes wakefulness and helps stabilize the sleep-wake state. The loss of orexin-producing neurons is the cause of narcolepsy, a condition characterized by excessive daytime sleepiness and an inability to maintain stable wakefulness.

The interplay between these sleep-promoting and wakefulness-promoting systems is a delicate balance. Insomnia can be conceptualized as a state of hyperarousal, where the wakefulness systems are overactive and override the homeostatic and circadian signals for sleep. This is why many modern hypnotic medications are designed to target and suppress these wakefulness-promoting neurotransmitters, a topic we will explore in detail later.

The Predictable Stages of a Night’s Sleep

As we sleep, our brain and body cycle through four distinct and predictable stages. These stages repeat themselves throughout the night, with each full cycle lasting approximately 90 minutes. A typical night of healthy sleep consists of four to six of these cycles. Understanding these stages is essential because many sleep disorders, and even the natural aging process, can disrupt this architecture, leading to non-restorative sleep.

The first three stages are collectively known as non-REM (NREM) or non-rapid eye movement sleep.

Stage 1: The Transition to Sleep

Stage 1 is the lightest and earliest phase of sleep, representing the transition from wakefulness to sleep.

• During this stage, the body has not yet fully relaxed, and brain waves begin to slow down from their daytime patterns.
• People in Stage 1 sleep can be awakened very easily. You might experience muscle twitches or the sensation of falling during this phase.
• This is a very short stage, typically lasting for less than 10 minutes.

Stage 2: Deeper Relaxation

In Stage 2, the body moves into a more subdued state as sleep deepens.

• There is a marked increase in parasympathetic nervous system activity, which is the “rest and digest” part of our autonomic nervous system.
• Muscles relax further, body temperature drops, and both heart rate and respiratory rate slow down.
• Brain activity continues to slow, punctuated by characteristic bursts of activity called sleep spindles and K-complexes, which are thought to play a role in memory consolidation and protecting sleep from external stimuli.
• This stage is significantly longer, lasting approximately 30 to 60 minutes in each cycle. We spend about half of our total sleep time in Stage 2.

Stage 3: Deep, Restorative Sleep

Stage 3 is the deepest and most physically restorative phase of sleep, often referred to as “slow-wave sleep.”

• During this stage, the body is in its most relaxed state. Heart rate, respiratory rate, and brain wave activity reach their lowest points.
• It is very difficult to awaken someone from Stage 3 sleep, and if you do, they will likely feel groggy and disoriented for several minutes.
• This phase is critical for physical repair, growth hormone release, and immune system function.
• Stage 3 sleep typically lasts for 20 to 40 minutes in each cycle and is more prominent in the earlier cycles of the night.

Stage 4: REM Sleep – The Mind’s Active Phase

The final stage of the sleep cycle is REM (Rapid Eye Movement) sleep. This stage is fascinatingly paradoxical.

• While the body is almost completely paralyzed (a state called atonia), which prevents us from acting out our dreams, the brain becomes highly active. Brainwave patterns during REM sleep look remarkably similar to those of an awake, alert brain.
• Heart rate and respiratory rate become irregular and may increase.
• This is the stage where most vivid dreaming occurs.

REM sleep is not just for dreaming; it is essential for our cognitive and emotional health. We now believe two critical processes occur during REM sleep:

1. Memory Consolidation: This is the process of converting newly acquired information and experiences from fragile, short-term memories into stable, long-term memories. REM sleep appears to be particularly important for procedural memory (learning new skills) and emotional memories.
2. Emotional Processing: REM sleep plays a vital role in our ability to recognize, understand, and regulate our emotions. It helps the brain process the emotional content of the day’s experiences, effectively “un-hooking” the emotion from the memory itself. This allows us to learn from emotional events without being perpetually traumatized by them. Inadequate REM sleep is strongly linked to mood dysregulation and increased emotional reactivity.

This stage can last anywhere from 10 to 60 minutes, and its duration tends to increase with each successive cycle throughout the night, meaning we get more REM sleep in the hours just before we wake up.

The Brain’s Nightly Housekeeping: The Glymphatic System

For a long time, the question of why we sleep remained one of biology’s great mysteries. Recent groundbreaking research has provided a compelling answer: sleep is the brain’s essential housekeeping period. A revolutionary discovery has been the identification of the glymphatic system, a previously unknown waste-clearance system unique to the brain and central nervous system.

The glymphatic system is a network composed of supportive brain cells called glial cells (specifically astrocytes) and the perivascular pathways—the tiny spaces that surround the brain’s blood vessels. This system functions as a kind of cerebral dishwasher, and we have learned that it is primarily active during sleep.

Here’s how it works: During deep, slow-wave sleep (Stage 3), the space between brain cells actually expands. This allows cerebrospinal fluid (CSF) to be pumped along the outside of arteries, wash through the brain tissue, and then collect along the veins, carrying away metabolic byproducts and cellular waste that have accumulated during the day.

This nightly cleaning process is profoundly important for long-term brain health. The waste products that the glymphatic system clears out include several toxic proteins that are implicated in the development of severe neurodegenerative diseases:

• Beta-amyloid plaques: The hallmark protein aggregates found in the brains of individuals with Alzheimer’s disease.
• Tau proteins: Another protein that forms neurofibrillary tangles inside neurons in Alzheimer’s disease and other “tauopathies.”
• Alpha-synuclein proteins: The primary protein component of Lewy bodies, which are characteristic of Parkinson’s disease and Lewy body dementia.

The link is clear and alarming: chronic poor sleep impairs glymphatic function. This leads to the insufficient clearance and subsequent accumulation of these toxic proteins in the brain, which is now believed to be a major contributing factor to the increased risk of developing neurodegenerative disorders like Alzheimer’s and Parkinson’s later in life.

This discovery underscores that sleep is not a passive state of rest but an active and vital biological process that is indispensable for maintaining a healthy brain.

The Critical Importance of Neuroplasticity and Sleep

Beyond waste clearance, sleep is fundamental to the brain’s ability to adapt, learn, and change—a concept known as neuroplasticity. Sleep provides the crucial downtime for neurons to rest, regenerate, and repair themselves from the metabolic stresses of waking activity.

Furthermore, sleep, particularly deep sleep and REM sleep, actively promotes synaptogenesis, which is the creation of new synaptic connections between neurons. These new connections are the physical basis of learning and memory. When we learn something new, sleep is required to solidify those neural pathways. Without adequate sleep, the brain’s capacity for neuroplasticity is significantly diminished, making it harder to learn, remember new information, and adapt to new challenges.

In my practice, this is a critical consideration, especially for patients recovering from injuries, such as a concussion or whiplash associated with a car accident. The brain’s ability to repair and rewire itself (neuroplasticity) is central to their recovery. When these patients also have insomnia—a very common comorbidity—their recovery process can be severely hampered. As a chiropractor, I can address the biomechanical and neurological dysfunctions in the cervical spine that can contribute to headaches and disrupt sleep. Simultaneously, as a functional medicine practitioner, I can use targeted nutrition and supplements to support neurotransmitter balance and reduce the neuroinflammation that impairs both sleep and brain repair. This integrative approach supports the brain’s inherent capacity for healing on multiple levels.

The Far-Reaching Consequences of Untreated Insomnia and Sleep Deprivation

The impact of chronic insomnia extends far beyond simply feeling tired the next day. It is a serious medical condition with profound and pervasive negative effects on nearly every aspect of an individual’s health and well-being. As a clinician, I see patients every day who come in feeling tired, sluggish, and fatigued. While these complaints might seem common, they are often the surface-level indicators of a much deeper issue: chronic insomnia. The impact of insufficient sleep weaves a web of dysfunction that affects every aspect of a person’s life.

Modern research has consistently shown that sleep deprivation is a significant public health issue. For my patients, this translates into tangible daily struggles. They report an increased risk for missing class or work, which has obvious economic and professional repercussions. But the toll is also deeply personal. I’ve observed that individuals struggling with insomnia are far more likely to isolate socially. The rates of loneliness and social isolation are markedly increased for those who are sleep-deprived. The energy required for social engagement isn’t there, leading to a withdrawal from friends, family, and community activities that are vital for mental well-being.

Exacerbation of Psychiatric Conditions

The relationship between sleep and mental health is intimately and bidirectionally linked. Poor sleep is not just a symptom of many psychiatric disorders; it is a powerful factor that can precipitate, exacerbate, and prolong them.

• Mood Disorders: For individuals with major depressive disorder, insomnia is one of the core diagnostic criteria. Lack of sleep can worsen feelings of hopelessness, anhedonia, and low energy. In bipolar disorder, a lack of sleep is a well-known trigger for manic or hypomanic episodes.
• Anxiety Disorders: Sleep deprivation amplifies activity in the amygdala, the brain’s fear center, leading to heightened anxiety, worry, and panic. This is particularly true for conditions like panic disorder and PTSD, where nightmares and hyperarousal at night are common.
• Substance Use Disorders: Insomnia is a major risk factor for relapse in individuals with alcohol use disorder and other substance use disorders. The discomfort and distress of being unable to sleep often drive individuals back to using substances in an attempt to self-medicate.
• Psychosis: Severe sleep deprivation can, in some individuals, induce psychotic symptoms such as paranoia and hallucinations, even in those without a pre-existing psychotic disorder.
• Suicidality: There is a robust and deeply concerning link between insomnia and suicide. Research has consistently shown that sleep deprivation is an independent risk factor for suicidal ideation, suicide attempts, and completed suicides. The emotional dysregulation, impaired judgment, and increased hopelessness caused by chronic sleeplessness can create a dangerously fertile ground for suicidal behavior.

Cognitive Decline: When the Brain Can’t Reboot

One of the most immediate and debilitating consequences of insomnia is the significant impairment of our patients’ cognitive function. This isn’t just about feeling “foggy”; it’s a measurable decline in the brain’s ability to perform its essential duties. This is consistently seen in declines in both work and academic performance.

When I work with patients, we break down these cognitive issues into specific areas of deficit:

• Decline in Alertness: This is the most fundamental problem. A sleep-deprived brain struggles to maintain focus, leading to lapses in attention that can be dangerous, whether driving a car or operating machinery.
• Difficulties with Learning and Memory: Sleep is crucial for memory consolidation. Without it, the ability to learn new information and recall it later is severely hampered. This particularly affects short-term and working memory, the systems we rely on to manage tasks, follow conversations, and process information in real-time. My patients often describe the frustrating experience of forgetting what they were about to say or being unable to retain information they just read.
• Slowed Processing Speeds: The brain’s processing speed literally slows down. Reactions are delayed, and thinking becomes more laborious. This can make even simple tasks feel overwhelming.
• Decline in Executive Function: This is a critical area that governs our higher-order thinking. Executive function is what we use for planning, making decisions, managing our time, and organizing complex tasks. You can see how a breakdown in this area can severely impact someone’s ability to fulfill their roles for the day, whether as a parent, an employee, or a student. The capacity for thoughtful, strategic action is replaced by reactive, disorganized behavior.

Impaired Motor Function: The Physical Dangers of a Tired Mind

The impact of sleep deprivation is not confined to the mind; it directly affects our motor function. The communication between the brain and the body becomes less precise. This manifests as:

• Increased Risk for Work-Related Injuries: In my practice, especially when dealing with personal injury cases, I frequently see a correlation between fatigue and accidents. A sleep-deprived worker has slower reflexes, impaired coordination, and poor judgment, creating a perfect storm for injury.
• Increased Risk for Motor Vehicle Accidents: The data on this is staggering and undeniable. Drowsy driving is as dangerous as drunk driving. Insomnia significantly elevates the risk of accidents, turning a routine commute into a life-threatening event.

From a chiropractic and rehabilitative perspective, this is crucial. When a patient comes to me after a car accident or a workplace injury, one of the first things I assess is their sleep pattern. Restorative sleep is fundamental to the healing process. Without it, inflammation persists, tissues repair more slowly, and the nervous system remains in a heightened state of stress, all of which can impede recovery from physical injury. Addressing the underlying sleep issue is often as important as the physical therapy itself.

A Compromised Immune System and Widespread Inflammation

More recently, research has illuminated the incredibly complex and bidirectional relationship between sleep and the immune system. This is a cornerstone of my functional medicine practice. I explain to my patients that when you don’t sleep, your body’s defense systems go haywire.

Poor-quality sleep has been unequivocally associated with central neuroinflammation—inflammation within the brain and central nervous system—and peripheral immune system compromise. The proof for this is not just theoretical; it’s found in tangible biomarkers:

• Increased Inflammatory Markers: We see consistent findings of increased cytokines (like IL-6 and TNF-alpha) and other inflammatory markers (like C-reactive protein) in the blood of sleep-deprived individuals. This suggests the body is in a chronic state of low-grade inflammation, a known driver of almost every chronic disease.
• Decreased Leukocyte Counts: The number and function of our white blood cells, the soldiers of our immune system, can be diminished. This leaves the body more vulnerable to infections.
• Reduced Antibody Titers from Vaccinations: This finding is particularly striking. Studies have shown that people who are sleep-deprived when they receive a vaccine produce fewer antibodies. Their immune response is blunted, making the vaccination less effective. This demonstrates just how fundamental sleep is to a properly functioning immune system.

Systemic Dysregulation: How Insomnia Wrecks the Body’s Harmony

The domino effect of poor sleep continues throughout the body’s interconnected systems. What I help my patients understand is that insomnia isn’t just a sleep problem; it’s a whole-body problem.

• Impaired Glucose and Lipid Metabolism: Sleep deprivation disrupts the body’s ability to manage blood sugar and fats. It promotes insulin resistance, a precursor to Type 2 diabetes, and dyslipidemia (unhealthy cholesterol levels), which contributes to cardiovascular disease.
• Maladaptive Changes in Hormonal Signaling: Sleep is when our hormonal orchestra is tuned. Poor sleep disrupts this delicate balance. For example, it leads to elevated levels of the stress hormone cortisol and decreased levels of growth hormone, which is essential for tissue repair. It also dysregulates the hunger hormones, ghrelin and leptin, leading to increased appetite and cravings for high-calorie foods.
• Dysregulation of the Gut Microbiome: The gut-brain axis is a hot topic in functional medicine, and sleep is a critical modulator. Lack of sleep can alter the composition and diversity of our gut bacteria, leading to a state of dysbiosis. This can cause digestive issues, further increase inflammation, and even affect mood and mental health.
• Impairment of Tissue Recovery: As a chiropractor, I emphasize this constantly. The body’s natural repair processes happen predominantly during deep sleep. For patients recovering from injury, whether it’s a sprained ankle or a herniated disc, sleep is non-negotiable. Without it, muscles, ligaments, and other tissues cannot adequately recover and rebuild. This is why integrative chiropractic care must always include a focus on sleep optimization.

Insomnia and Chronic Disease: A Deadly Connection

The cumulative effect of this systemic disruption is a stark increase in the risk for serious health consequences. We now have a large body of evidence demonstrating that chronic, untreated insomnia leads to increased morbidity and mortality.

There is a bidirectional relationship with multiple comorbidities. This means that not only does insomnia increase the risk of these conditions, but these conditions also worsen insomnia, creating a vicious cycle. Some of the most common and serious chronic conditions linked to poor sleep include:

• Cardiovascular and Cerebrovascular Disease: Increased risk of hypertension, heart attack, and stroke.
• Kidney Disease: The 24-hour circadian clock plays a vital role in kidney function, and disruption can accelerate kidney disease progression.
• Numerous Types of Cancer: Research has linked poor sleep to an increased risk for several cancers, including breast, colorectal, and prostate cancer, likely due to the combination of immune suppression and chronic inflammation.
• Diabetes: As mentioned, the link to insulin resistance is strong and direct.
• Dementia: This is perhaps one of the most frightening connections. High-quality studies have shown that patients with insomnia have an over 50% increased risk for Alzheimer’s disease compared to those without insomnia. The brain’s glymphatic system, which clears metabolic waste like amyloid-beta plaques, is most active during sleep. Poor sleep impairs this “housekeeping” process, allowing these toxic proteins to accumulate.

Even more concerning is the data on mortality. Older adults with insomnia have a two-fold increased risk for mortality compared to their peers who sleep well. With all of these serious consequences in mind, you can see why I, and the broader medical community, now recommend that we assess our patients’ sleep quality regularly. It’s not a luxury; it’s a fundamental pillar of health.

Assessment of Insomnia: Making Sleep a Vital Sign

Given the profound and systemic impact of insomnia on health, the clinical approach to its assessment has evolved significantly. It is now strongly recommended that we consider sleep quality as a vital sign, just as pain was added as the fifth vital sign in recent decades. This isn’t something to be asked about only when a patient brings it up; it should be a routine part of every clinical encounter.

In my practice, this screening is integrated right from the beginning, often during the initial nursing or MA triage. This proactive approach ensures we don’t miss this critical piece of the health puzzle.

Streamlining the Initial Assessment

To expedite this assessment in a busy clinical setting, we use validated, high-quality self-report questionnaires. These tools are efficient for the patient to complete and give us a standardized, quantitative measure of their sleep issues. Two of the most respected and widely used tools are:

• PSQI (Pittsburgh Sleep Quality Index)
• ISI (Insomnia Severity Index)

The Insomnia Severity Index (ISI) is particularly useful for its brevity and focus. It quickly scores the severity of sleep-onset, sleep-maintenance, and early-morning awakening insomnia, as well as the degree of distress and daytime impairment. A positive screening on one of these questionnaires triggers a more thorough evaluation.

The Comprehensive Sleep Evaluation: Using the OLD CART Mnemonic

When a patient screens positive for insomnia, I sit down with them for a deeper dive. It’s not enough to know that they are sleeping poorly; I need to understand the how and why. A useful mnemonic to guide this holistic evaluation is OLD CART, which helps to get a complete picture of their sleep issues:

• O – Onset: When did the sleep problems begin? Was it associated with a specific event, like a new job, a traumatic experience, or the start of a new medication?
• L – Location: While this usually applies to pain, in the context of sleep, we can adapt it to ask: Where do you sleep? Is the environment conducive to rest? Is it dark, quiet, and cool?
• D – Duration: How long do the periods of wakefulness last? How many hours of actual sleep are you getting per night?
• C – Characteristics: What is the nature of the problem? Is it trouble falling asleep (sleep-onset insomnia), waking up frequently during the night (sleep-maintenance insomnia), or waking up too early and being unable to return to sleep (early-morning awakening)?
• A – Aggravating/Alleviating Factors: What makes it worse? (e.g., stress, caffeine, screen time). What makes it better? (e.g., a warm bath, reading a book).
• R – Radiation: Not applicable here.
• T – Timing/Treatment: Is there a pattern to the sleeplessness? Does it only happen on work nights? What have you tried so far to treat it, and what was the result?

Along with this structured inquiry, I specifically want to assess their sleep routine. I ask them to walk me through the hours leading up to bedtime. I’m keeping a sharp eye out for any maladaptive habits—behaviors that they may think are harmless or even helpful but are actually sabotaging their sleep. We’ll discuss these in detail later.

A critical component of this evaluation is determining if there is impaired daytime functioning because of their sleep problems. I ask pointed questions: “How is your energy during the day? Are you finding it hard to concentrate at work? Have you been more irritable with your family? Do you feel you need caffeine to get through the afternoon?” This connects their nighttime problem to their daytime reality, which is often a powerful motivator for change.

The Role of Technology: Smartwatches vs. Sleep Diaries

In today’s tech-savvy world, many of my patients will come in and report their sleep quality based on smartphone or smartwatch data. While I appreciate their diligence, I have to counsel them that, at this time, the research on the reliability of these consumer-grade devices is not there yet. The data they provide can be very unreliable, often overestimating sleep or misinterpreting periods of quiet wakefulness as sleep. This can lead to either false reassurance or increased anxiety about sleep—a phenomenon sometimes called “orthosomnia.”

Instead, the gold standard for subjective sleep tracking remains the sleep diary. This can be done simply with a pen and paper, or by using various validated apps designed for this purpose. I ask the patient to log:

• The time they went to bed.
• The estimated time it took to fall asleep.
• The number of times they woke up during the night.
• The total time they were awake during the night.
• The time they woke up in the morning.
• The time they got out of bed.
• The quality of their sleep on a simple scale (e.g., 1-5).
• Any naps taken during the day (time and duration).
• Use of caffeine, alcohol, and medications.

This diary provides invaluable, nuanced information that a wearable device cannot capture. It helps both me and the patient identify patterns and behaviors that are influencing their sleep.

Connecting the Dots: Chronic Health Conditions and Sleep

Finally, a crucial part of my assessment, and where the collaboration with Dr. Cardenas is vital, is to take a close look at the patient’s chronic health conditions and medications. As the chart below illustrates, a wide array of common issues can directly interfere with sleep.

Condition/Factor	How It Disrupts Sleep
Chronic Pain (e.g., Arthritis, Fibromyalgia, Back Pain)	Pain signals prevent the brain from entering deep, restorative sleep stages.
Cardiovascular Disease (e.g., Heart Failure)	Can cause shortness of breath when lying down (orthopnea), leading to awakenings.
Respiratory Conditions (e.g., Asthma, COPD)	Coughing, wheezing, and difficulty breathing can fragment sleep.
Gastroesophageal Reflux Disease (GERD)	Stomach acid backing up into the esophagus causes pain and discomfort, especially when lying flat.
Endocrine Disorders (e.g., Thyroid Issues, Diabetes)	Hormonal imbalances can cause night sweats (hyperthyroidism) or nocturia from high blood sugar (diabetes).
Neurological Disorders (e.g., Parkinson’s, Restless Legs Syndrome)	Involuntary movements or an uncontrollable urge to move the limbs directly prevent rest.
Mental Health Conditions (e.g., Anxiety, Depression)	Rumination, worry, and changes in brain chemistry are powerful drivers of insomnia.
Nocturia (Frequent Nighttime Urination)	Can be caused by prostate issues, bladder problems, or other medical conditions.
Medications (e.g., Stimulants, Steroids, some Antidepressants, Decongestants)	Many common medications have stimulant or other side effects that interfere with sleep architecture.

If we can help address these underlying issues or work with Dr. Cardenas to figure out a treatment plan to manage them better—perhaps by changing the timing of a medication or implementing strategies to reduce GERD at night—we can also help improve their sleep quality. This holistic, root-cause approach is fundamental to long-term success.

When to Refer to a Sleep Medicine Specialist

While most cases of insomnia can be safely and effectively addressed in a primary care or integrative outpatient setting like ours, it’s important to recognize when a referral to a sleep medicine specialist is indicated. The two most common situations are:

1. Suspected Sleep Apnea: If a patient’s symptoms strongly suggest obstructive sleep apnea (OSA), a formal sleep study (polysomnography) is necessary for diagnosis.
2. Treatment-Resistant Insomnia: If the insomnia is resistant to our initial treatment approaches, especially after trying more than one strategy, a specialist can offer more advanced diagnostics and therapies.

I am always on the lookout for the classic symptoms of sleep apnea, which include:

• Chronic, unrefreshing sleep (waking up feeling just as tired as when they went to bed)
• Nocturia (waking up to urinate multiple times)
• Loud and recurrent snoring (often reported by a bed partner)
• Gasping or choking during sleep (also usually a witnessed event)
• Witnessed apneic episodes (a bed partner notices they stop breathing)
• Morning dry mouth or headaches
• Significant daytime sleepiness and fatigue

Especially in patients who are endorsing multiple or most of these symptoms, particularly if they also have risk factors like obesity or a large neck circumference, the best course of action is to refer them to a sleep medicine specialist for a definitive diagnosis and treatment, which is often a CPAP machine.

A Multimodal Strategy for Treating Chronic Insomnia

Fortunately, today we have a wealth of effective treatment options for our patients struggling with chronic insomnia. The key to success, however, is not to rely on a single “magic bullet.” Instead, we must formulate a multimodal and individualized strategy. Decades of research have found that many individual treatment options, when used in isolation, often have only a modest to small effect size on improving sleep quality. The real power lies in approaching the problem from many angles simultaneously.

Our comprehensive plan at the clinic involves a synergistic blend of behavioral therapies, relaxation techniques, patient education, and, when necessary, the judicious use of medication, all layered upon a foundation of chiropractic and functional medicine.

Relaxation Techniques: Calming the Mind and Body

For many people with insomnia, the core problem is a hyperaroused nervous system. Their mind is racing, and their body is tense. They are in a state of “fight or flight” when they should be in “rest and digest.” Therefore, a primary goal is to teach the patient how to shift their physiological state actively. There are many effective ways to help calm the mind at night.

• Meditation: Mindfulness meditation, in particular, trains the brain to observe thoughts without judgment, reducing the power of anxious rumination. It helps anchor the individual in the present moment rather than worrying about the past or future.
• Guided Imagery: This technique involves using directed thoughts and suggestions to create relaxing mental images and scenarios. It’s like taking a mini-vacation in your mind, which can effectively distract from sleep-related anxiety.
• Progressive Muscle Relaxation (PMR): This is a powerful somatic technique. The patient systematically tenses and then releases different muscle groups throughout the body. This process not only releases physical tension but also highlights the difference between a state of tension and a state of relaxation, giving the patient a tangible tool to induce calm.

Many of these skills can be learned with the help of a therapist. However, to increase access for patients, there are now many excellent smartphone apps that teach these techniques. Apps like Calm, Headspace, and Insight Timer offer guided meditations, PMR exercises, and sleep stories that can be incredibly helpful.

From a chiropractic perspective, these techniques are a perfect complement to what I do. A chiropractic adjustment can help down-regulate an overactive sympathetic nervous system, creating a state of greater neurological balance. Teaching the patient PMR and breathing exercises empowers them to maintain that calmer state at home, reinforcing the benefits of their treatment.

Cognitive Behavioral Therapy for Insomnia (CBTI): The Gold Standard

When it comes to non-pharmacological treatments, one therapy stands head and shoulders above the rest: Cognitive Behavioral Therapy for Insomnia, or CBTI for short.

CBTI is so effective for improving sleep quality that it is now considered a first-line treatment option for chronic insomnia by major medical organizations, including the American College of Physicians. What is remarkable about CBTI is that it’s not only effective in the short term, but its benefits are long-lasting, often continuing even once the patient stops seeing the clinician. It gives them the skills for a lifetime of better sleep.

Unfortunately, a major barrier is that CBTI can be difficult to access. It seems that not many clinicians are formally credentialed in CBTI, and so it can be hard to locate qualified therapists. However, this is changing. There are now many digital CBTI (d-CBTI) options available, such as smartphone apps or telemedicine platforms, if the patient is willing to use those technologies. These are nearly as effective as in-person therapy.

Deconstructing CBTI: Rewiring the Brain for Sleep

While licensed therapists or specialized digital programs mainly provide CBTI, it’s essential for me as a primary contact provider to understand the basic tenets of this psychotherapy. The more I understand it, the better I can explain its benefits and promote it to my patients.

CBTI, just like classic CBT, is a brief, structured psychotherapy with proven and long-lasting benefits. It typically involves 4-8 sessions. The overarching goal is to break the vicious cycle of dysfunctional thoughts and behaviors that perpetuate insomnia.

The Cognitive Component: Changing Your Thoughts About Sleep

One of the primary goals of CBTI is to reduce sleep-related worry. This is the cognitive portion of the therapy. The aim is to shift the patient away from a mindset centered around “trying very hard to fall asleep” to one of allowing sleep to happen naturally.

Anyone who has experienced insomnia knows the feeling: the harder you try to sleep, the more awake you become. This effort is counterproductive and feeds a cycle of anxiety and frustration. CBTI works to dismantle this. The process involves:

1. Identifying Cognitive Distortions: The therapist helps the patient identify their inaccurate or unhelpful thoughts and beliefs related to sleep. These are automatic negative thoughts that pop into their head, such as:

• • “I’ll never be able to fall asleep.”
  • “If I don’t get 8 hours of sleep tonight, I won’t be able to function tomorrow.” (Catastrophizing)
  • “I’ve always been a bad sleeper; nothing will ever change.” (All-or-nothing thinking)

• Challenging These Distortions: Once identified, the therapist teaches the patient how to challenge these thoughts using logic and evidence. For example, they might ask, “Have you ever had a bad night’s sleep and still managed to get through the next day?” The answer is almost always yes, which refutes the catastrophic belief.
• Replacing and Reframing: The final step is to replace the negative, unhelpful thought with a more realistic and adaptive one. For example, instead of “I’m going to be a wreck tomorrow,” the patient might reframe it as, “I may be a bit tired tomorrow, but I will still be able to do what I need to do. I will rest when I can and focus on good sleep habits tonight.”

This cognitive restructuring is incredibly empowering. It helps to reduce the anxiety and frustration that can come with insomnia, which, in turn, makes it easier for the body’s natural sleep drive to take over.

The Behavioral Component: Changing Your Actions

The second pillar of CBTI is to identify and eliminate ineffective sleep-related behaviors. This is the behavioral component, and it primarily involves two key areas:

1. Addressing Sleep Hygiene: This is a big part of CBTI. Sleep hygiene refers to the set of habits and environmental factors that are conducive to sleeping well. We will discuss these specific recommendations in the next section. A major part of sleep hygiene is addressing the patient’s substance use, and this includes counseling on the sleep-disrupting effects of alcohol, caffeine, and nicotine.
2. Counseling on Relaxation Techniques: As mentioned earlier, CBTI incorporates training in effective relaxation techniques such as meditation and progressive muscle relaxation. The goal is to give the patient a toolkit of skills to help them wind down, relax, and manage the physiological hyperarousal that prevents sleep.

To address both the cognitive and behavioral parts of CBTI, the therapist will often assign homework for the patient to practice at home between sessions. This might include keeping a sleep diary, practicing cognitive reframing, or performing a progressive muscle relaxation exercise before bed.

The Goal of Sleep Efficiency and the Power of Sleep Restriction

All of this work—both cognitive and behavioral—is meant to help improve the patient’s sleep efficiency. This is a key metric in CBTI.

Sleep Efficiency = (Total Time Spent Asleep / Total Time Spent in Bed) x 100

For some of my patients, they may only be getting five and a half hours of actual sleep, but they are lying in bed for eight hours. This means they are spending two and a half hours awake in bed, tossing, turning, and getting frustrated. Their sleep efficiency is only about 69%. This is not efficient. In fact, it’s counterproductive, as it teaches the brain to associate the bed with wakefulness and anxiety.

Ideally, a healthy sleeper’s efficiency would be somewhere between 85% and 95%. The goal of CBTI is to get the patient into that range.

One of the most powerful—and initially counterintuitive—techniques used in CBTI to achieve this is called sleep restriction (or more accurately, time-in-bed restriction). The process works like this:

1. Calculate Average Sleep Time: Based on the sleep diary, the therapist determines the average amount of sleep the patient is currently getting per night (e.g., 6 hours).
2. Restrict Time in Bed: The therapist will then advise the patient to reduce the amount of time they are allowed to spend in bed, setting a “sleep window” that is closer to their actual sleep time. So, initially, the patient may be advised to stay in bed for only around six hours per night. For example, if they need to wake up at 6:30 AM, they would be instructed not to go to bed before 12:30 AM, no matter how tired they feel.
3. Build Sleep Drive: This initial phase can be difficult and may lead to some daytime sleepiness. However, it powerfully builds up the homeostatic sleep drive. By restricting the opportunity for sleep, the body’s natural pressure to sleep becomes much stronger. This makes it easier to fall asleep quickly and stay asleep.
4. Gradually Increase Time in Bed: As the patient’s sleep efficiency improves (e.g., they are sleeping for nearly the entire 6-hour window), the patient will be advised to gradually increase the time spent in bed, usually in 15-minute increments. This process continues until the patient is getting the optimal amount of sleep for them while maintaining a high sleep efficiency.

This technique is incredibly effective in improving both sleep efficiency and overall sleep quality. It works by re-consolidating sleep and re-associating the bed with sleeping quickly and soundly.

Digital Options for CBTI

While finding a live therapist can be a challenge, I always inform my patients about the digital options available. One excellent, free smartphone app that the U.S. Department of Veterans Affairs developed is called CBTI Coach. It guides users through the entire CBTI process, including sleep restriction, cognitive exercises, and relaxation techniques.

There are also other subscription-based apps like Headspace or Calm that, while not full CBTI programs, have many great tutorials on learning those relaxation and insomnia management techniques. The only downside, or probably the biggest downside, to these types of digital options is that the patient won’t get any one-on-one guidance or mentoring. For some, this lack of accountability and personalization can be a barrier. However, for self-motivated individuals, they can be a fantastic and accessible resource.

Balancing Body and Metabolism- Video

Sleep Hygiene: The Foundation for a Good Night’s Rest

Regardless of the specific treatment plan we decide on—whether it’s CBTI, medication, or a combination—it is absolutely vital that I spend time educating my patient on sleep hygiene. This term describes the collection of behavioral and environmental recommendations designed for optimizing sleep.

Think of sleep hygiene as setting the stage for sleep. If the stage is cluttered, noisy, and brightly lit, it’s going to be very hard for the main actor—sleep—to perform. These tips and behaviors will improve their likelihood of sleeping well and are foundational to any successful insomnia treatment.

Creating a Sanctuary for Sleep

The first and most important step is advising the patient to create a calm, quiet, and comfortable bedroom environment. The bedroom should be a sanctuary for rest, not a multi-purpose room for work, entertainment, and stress. This includes:

• Cool Temperature: Lower the room temperature, if possible, or use fans. A drop in core body temperature is a natural signal for sleep onset. A cool room facilitates this process.
• Darkness: The room should be as dark as possible. This means using blackout curtains, covering or removing electronics with lights, and even wearing an eye mask if needed. Light exposure, especially blue light, suppresses melatonin production.
• Quiet: Minimize noise. If outside noise is an issue, consider using earplugs or a white noise machine to mask disruptive sounds.

Managing Your Schedule and Activities

• Minimize Napping: While a short “power nap” can be restorative for some, long or late-afternoon naps can disrupt the nighttime circadian rhythm and reduce the sleep drive. If my patients do nap, I recommend keeping it under 30 minutes and doing it before 3 PM.
• Avoid Evening Stimulants:

• • Caffeine: I advise patients to avoid caffeine entirely after noon, or at least for 8-10 hours before their intended bedtime. Caffeine has a long half-life and can significantly interfere with the ability to fall asleep.
  • Alcohol: Many people believe alcohol is a good sleep aid because it can make you feel drowsy. However, while it might help with sleep onset, as the body metabolizes it, it leads to fragmented, poor-quality sleep in the second half of the night. It’s a major disruptor of REM sleep. I strongly recommend avoiding alcohol, especially right before bedtime.

• Maintain a Consistent Sleep Schedule: This is one of the most powerful sleep hygiene tools. I recommend that patients adhere to a consistent wake-up time and bedtime, even on weekends and holidays. This helps to anchor the body’s internal clock, or circadian rhythm, making it easier to fall asleep and wake up naturally. Wake-up time is actually more important than bedtime for setting this clock.
• Time Your Exercise: While daily exercise can significantly improve sleep quality, it should not be done too late in the day. Strenuous exercise raises core body temperature and releases stimulating hormones like cortisol and epinephrine, which can cause an awakening effect. It’s best to finish vigorous workouts at least 3-4 hours before bed. Gentle, relaxing exercises like stretching or yoga are fine in the evening.

The Stimulus Control Protocol: Re-Training the Brain

Perhaps most importantly, I must talk to them about reducing their stimulus exposure towards the evening. This is a core component of CBTI known as Stimulus Control Therapy. The goal is to break the association between the bedroom and a state of anxious wakefulness.

• Reduce Screen Time: This is especially crucial in modern life. The blue light emitted from phones, tablets, TVs, and computers is particularly potent at suppressing melatonin and tricking the brain into thinking it’s still daytime. It’s really recommended that patients put away their screens in the one to two hours leading up to bedtime to help promote a natural sleepy feeling. Instead, they should engage in relaxing, non-stimulating activities.
• Bed is for Sleep and Sex Only: I recommend that patients only use the bed for sleep and sex, if they are sexually active. They should not work, eat, watch TV, or worry in bed. This helps to create a powerful conditioned response: getting into bed becomes a strong cue for sleep.
• Cover Bedside Clocks: Clock-watching is a major source of anxiety for people with insomnia. They watch the minutes and hours tick by, calculating how little sleep they’re getting, which only increases their stress and arousal. I advise them to turn the clock around or cover it, so they don’t end up watching the clock and fueling that frustration.
• The 15-20 Minute Rule: This is another counterintuitive but highly effective rule. I recommend that if the patient has been lying in bed, tossing and turning for more than 15 to 20 minutes, they should actually get out of bed. They should go to another room and do something that requires low energy and low light, such as reading a physical book (not on a screen), journaling, listening to calm music, or practicing meditation. The key is not to get back into bed until you are actually feeling tired and sleepy. This rule prevents the bed from becoming a place of struggle and reinforces the idea that the bed is for sleeping, not for being awake.

These sleep hygiene principles are not just suggestions; they are evidence-based strategies that form the bedrock of any successful approach to overcoming insomnia.

Exploring Natural Supplements for Insomnia: A Cautious Approach

As a functional medicine practitioner, I am often asked about natural remedies for sleep. Patients are understandably drawn to supplements like valerian root, passionflower, and chamomile, which have been used for centuries in traditional medicine to promote relaxation and sleep. They are widely available, generally affordable, and perceived as “safer” alternatives to prescription medications. However, from an evidence-based perspective, the picture is more complex.

When we look at the scientific literature, the research supporting the efficacy of these supplements for insomnia is, frankly, limited and often inconsistent (Savage, Zick, & Ko, 2021). While some small studies suggest potential benefits, larger, more rigorous clinical trials are needed to confirm their effectiveness and establish standardized, safe dosing guidelines.

Let’s break down the current understanding:

• Affordability and Accessibility: One of the primary advantages of these supplements is their low cost and wide availability in pharmacies, health food stores, and online. This makes them an accessible first step for many people struggling with mild sleep disturbances.
• Low Risk Profile: Generally, these herbal supplements are associated with a low risk of serious adverse effects. Side effects are typically mild and may include dizziness, headache, or gastrointestinal upset. This favorable safety profile is a significant part of their appeal.
• The Research Gap: The main issue lies in the lack of robust scientific evidence. Without well-designed, placebo-controlled studies, we cannot definitively say that they work better than a placebo. Furthermore, the supplement industry is not as tightly regulated as the pharmaceutical industry, raising concerns about product purity, potency, and consistency on the market.
• Dosing Dilemma: This lack of research creates a significant clinical challenge: we do not have clear, evidence-based guidelines for ideal dosing. The effective dose can vary widely depending on the preparation, the part of the plant used, and the individual’s metabolism. This makes it difficult for practitioners like myself to provide precise recommendations.

Given these considerations, my clinical stance is one of cautious optimism. While I acknowledge their potential and low-risk profile, I must emphasize that more research is needed before they can be recommended as a primary, reliable treatment for chronic insomnia. My role is to educate patients about both the potential benefits and the scientific uncertainties, empowering them to make informed decisions. In our practice, we often use these as part of a broader lifestyle-based approach, but we do not rely on them as a standalone cure. Along with melatonin, there are many other supplements or natural or complementary alternative options that patients may be interested in trying. These include magnesium, valerian root, and lavender extract, to name a few. Unfortunately, at this time, these are not recommended by major clinical guidelines for the treatment of chronic insomnia due to a lack of consistent, high-quality evidence supporting their efficacy and safety. While some individuals may find them helpful, the scientific backing is not yet strong enough for a general recommendation. This is an area where more research is needed.

Pharmacotherapy: Navigating Hypnotic Medications for Safe Use

When behavioral strategies alone are not enough, or when a patient needs immediate relief from severe insomnia, we may consider prescription hypnotic medications. However, this decision is never taken lightly. There are several crucial topics I review in detail with my patient before they start any sleep medication to ensure they understand the risks and can use them safely and effectively. These medications can be a valuable tool, particularly for providing short-term relief while the patient is learning the behavioral skills of CBTI. However, they are not without their risks.

It is absolutely crucial to have an open conversation with your patient, to weigh the potential risks and benefits, and to collaborate with them to formulate the best option based on their unique needs and characteristics.

It is also important to note—and I always make this clear to my patients—that a lot of these medications have a strong placebo effect. The very act of taking a pill that you believe will help you sleep can reduce anxiety and, in itself, promote sleep. This isn’t to diminish their pharmacological effects but to highlight the powerful role of mindset in the experience of insomnia.

Core Principles of Prescribing

1. Use the Lowest Effective Dose as Little as Needed: The mantra is “start low, go slow.” We always begin with the smallest possible dose that provides a benefit and encourage the patient to use it only on nights when they truly need it, rather than automatically every night. This minimizes the risk of side effects and dependency.
2. Understand the Risks: There are several risks commonly identified with our hypnotics. It’s my responsibility to counsel patients on these clearly:

• • Risk for Falls and Injuries: Many sleep aids can cause dizziness, grogginess, and impaired coordination, both during the night and the next morning (the “hangover effect”). This is particularly dangerous for older adults.
  • Episodes of Confusion: Some patients, especially the elderly, can experience episodes of confusion or delirium.
  • Complex Sleep Behaviors: This is a serious potential side effect, which includes activities like sleepwalking, sleep driving, and sleep eating. The person is technically asleep and has no memory of the event afterward. This can be extremely dangerous.
  • Tolerance and Dependency: With some of our medications, especially the controlled substances, the body can develop a tolerance, meaning they need a higher dose for the same effective response. They may also develop a physical or psychological dependency on the medication to sleep.

I weigh these risks very carefully and counsel my patients, especially our older adults, to ensure their safety. In my chiropractic and rehabilitative practice, preventing falls is a top priority, and prescribing these medications adds another layer of complexity that must be managed.

• Avoid Mixing with Other Sedating Substances: I strongly advise my patients not to mix these medications with any other sedating substances. This is for obvious reasons, as the combination can lead to excessive sedation, respiratory depression, and even accidental overdose. This includes:

• • Alcohol
  • Cannabis
  • Muscle Relaxants
  • Opioids
  • Certain Antihistamines

• A Warning on OTC Antihistamines: For many years, people have used over-the-counter (OTC) antihistamines containing diphenhydramine (e.g., Benadryl, Tylenol PM, Advil PM) as sleep aids. However, it’s definitely not recommended for patients to use these anymore for chronic insomnia. Long-term use of these anticholinergic drugs has been shown to increase the risk for patients experiencing mild cognitive impairment and even dementia.

Mechanisms of Action: How Sleep Medications Work

As you can see from the following discussion, we have several different types of hypnotics available, each with a varying mechanism of action. Understanding how they work helps us choose the right medication for the right patient.

• Antidepressants: Certain antidepressants, at low doses, reduce wakefulness by antagonizing histamine H1 receptors. Histamine is a primary wakeful neurotransmitter in the brain. By blocking its action, these drugs promote drowsiness.
• Benzodiazepines: These medications promote sleepiness by enhancing GABA signaling. GABA (gamma-aminobutyric acid) is the brain’s primary inhibitory neurotransmitter; it calms things down. Benzodiazepines bind to allosteric sites on numerous GABA-A subtype receptors, making them more responsive to the GABA that is naturally present.
• “Z-drugs” (Nonbenzodiazepine Receptor Agonists): Like benzodiazepines, our Z-drugs also promote sleepiness by enhancing GABA signaling. However, they do so via a more selective agonism of allosteric sites on the specific alpha-1 subtype of the GABA-A receptor. This selectivity is thought to be responsible for their hypnotic effects with fewer anxiolytic or muscle relaxant properties compared to benzodiazepines. (The exception is eszopiclone, which is less selective and binds to multiple GABA-A subtypes).
• Positive Allosteric Modulators (PAMs): It’s important to understand that both benzodiazepines and Z-drugs are called positive allosteric modulators. This means that they bind to a site on the receptor that is separate from the site where the endogenous agonist (in this case, GABA) binds. When they do this, it increases the affinity and efficacy of that endogenous agonist. They don’t activate the receptor on their own; they make the brain’s own “off switch” work much better. The take-home message with these classes is that they enhance GABA signaling.
• DORAs (Dual Orexin Receptor Antagonists): This is a newer class of medication. These reduce wakefulness by antagonizing both orexin-1 and orexin-2 receptors. Orexin (also called hypocretin) is another powerful wakeful chemical released by the hypothalamus. By blocking orexin, these drugs effectively turn off the brain’s “wake-up” signal.
• Melatonin Agonists: These drugs promote sleepiness via selective agonism of melatonin MT1 and MT2 receptors, primarily located in the suprachiasmatic nucleus (SCN) of the hypothalamus, the body’s master clock. They essentially mimic the action of the body’s natural sleep hormone, melatonin, to help regulate the circadian rhythm.

A Closer Look at the Medications

Let’s break down the specific medications within each class, discussing their uses, advantages, and disadvantages.

Antidepressants for Insomnia

First up, we have our antidepressants. Currently, we only have one medication in this class that is formally FDA-approved for insomnia, and that is doxepin.

• Doxepin (Silenor): It’s been approved at a very low dose range of 3 to 6 milligrams. This is much, much lower than the 75-300 mg doses used for treating actual depression. Doxepin is technically a tricyclic antidepressant (TCA), but at these low doses, it really is just a potent antihistamine. As we discussed, it blocks wakefulness by antagonizing the histamine H1 receptor.
  • Advantages:

• • • It can be used long-term for many patients.
    • It has a very low risk for dependency and tolerance. Doxepin is not a controlled substance like most of our other sleep aids, which is a significant benefit.
    • It’s best used for patients who struggle to stay asleep throughout the night. It works well to address mid-night awakenings or early morning awakenings, helping to keep them asleep for many hours.
    • Doxepin is generally very well tolerated, with an extremely low risk for side effects for most patients.

• • Disadvantages:

• • • One of the most common side effects we see is patients complaining of drowsiness the next morning. Some ways to help reduce that would be to advise the patient to lower their dose or to take it earlier in the evening.

• Off-Label Use: It’s important to note that while in practice, many clinicians use other antidepressants as sleep aids, they do not have an FDA indication for insomnia. This would include medications like trazodone, mirtazapine, and amitriptyline. The overall research guidelines for insomnia did not support using these off-label, stating there wasn’t enough high-quality evidence. However, I will say that in my own clinical practice, I have seen great success with these options, and I often recommend them over some of the other sleep aids we will talk about due to their non-controlled status and favorable side-effect profiles in many patients. But it is crucial to remember that this is off-label use, and this must be discussed with the patient.

Benzodiazepines

Next up, we have our benzodiazepines. As you can see, several options within this class of medication are FDA-approved for insomnia.

Medication	Common Brand Name	Primary Use
Triazolam	Halcion	Sleep-onset insomnia (very short-acting)
Temazepam	Restoril	Sleep onset and maintenance
Estazolam	ProSom	Sleep onset and maintenance
Flurazepam	Dalmane	Sleep onset and maintenance
Quazepam	Doral	Sleep onset and maintenance

• Triazolam is pretty unique because it’s such a short-acting medication. It’s really best for people having trouble falling asleep, but it won’t do much to keep them asleep. The other four work well for both trouble falling asleep and staying asleep.
• Advantages:

• • Because these medications have been around for a long time, they are all generic and tend to be very affordable, especially compared to some newer treatment options.

• Disadvantages:

• • Because they’re benzodiazepines, these medications come with quite a lot of risk, and therefore they should only be used for short-term treatment (e.g., 2-4 weeks).
  • Benzodiazepines have a very high risk for tolerance, or reduced effectiveness over time.
  • Patients can also be at risk for abusing them or becoming dependent upon them.
  • Benzodiazepines carry a significant risk for causing respiratory depression, confusion, and falls. These risks are especially pronounced for our older patients and those with pre-existing mild cognitive impairment or other health conditions that may predispose them to injuries or falls. This is why their use is heavily discouraged in older people.

Benzodiazepine Receptor Agonists (“Z-drugs”)

Next, we have our benzodiazepine receptor agonists, also commonly referred to as Z-drugs. We have three primary medications under this class:

Medication	Common Brand Name	Primary Use
Eszopiclone	Lunesta	Sleep onset and maintenance
Zaleplon	Sonata	Sleep-onset; middle-of-the-night awakenings
Zolpidem	Ambien, Ambien CR, Edluar, Zolpimist	Sleep onset and maintenance

• These have also been around for quite a while and, as mentioned, work a little differently than benzodiazepines due to their receptor selectivity. For this reason, they tend to have a lower risk for tolerance and dependency compared to benzodiazepines. That’s a huge advantage for them.
• Advantages:

• • They offer a wide variety of onset and duration of action so that you can individualize your treatment plan based on the patient’s specific issues.
  • For patients with early morning awakening or intermittent issues where they wake up in the middle of the night and can’t go back to sleep, zaleplon and the sublingual formulation of zolpidem (Edluar) are great choices. They have a very rapid onset and a very short half-life. Patients can often use these late into the night (provided they have at least 4 hours left to sleep) to help them get a few more hours of rest and wake up feeling refreshed. They still have to be used cautiously, but they are an excellent choice for this type of issue.
  • Eszopiclone and the controlled-release (CR) formulation of zolpidem work really well for both trouble with sleep onset and maintenance. They help patients fall asleep and stay asleep for many hours.
  • Like benzodiazepines, because these have been around a while, they are very affordable, available as generics, and easily accessible to patients even without insurance.

• Disadvantages:

• • One very notable drawback to this class of hypnotics is that they have been demonstrated to have the highest risk for complex sleep behaviors. This includes sleepwalking, sleep driving, sleep eating, etc. You must counsel your patients on this risk and closely monitor for any such behaviors because, obviously, the medication can put the patient at risk for injury or worse.

Dual Orexin Receptor Antagonists (DORAs)

Here, we have our newest class of hypnotics, known as the dual orexin receptor antagonists or DORAs for short. These work differently than our other sleep aids by blocking the wake-promoting neurotransmitter, orexin. We currently have three FDA-approved medications in this class:

Medication	Common Brand Name
Suvorexant	Belsomra
Lemborexant	Dayvigo
Daridorexant	Quviviq

• Important Counseling Point: A commonality they all have is that food, especially high-fat food, can delay their absorption and onset of action. This is also true for eszopiclone. It’s important to counsel our patients on this. We should advise our patients to avoid eating a heavy meal before going to bed, which is also good sleep hygiene in general. But it provides another reason when you’re looking at these specific medications.
• Advantages:

• • It seems that they are much less risky than our benzodiazepines and our Z-drugs because of their different mechanism of action.
  • While they are still classified as controlled substances (Schedule IV), they have strong research supporting that they can be used long-term, which makes them a great option for our patients with chronic insomnia.
  • They work really well for helping with sleep maintenance, helping patients sleep throughout the night and avoiding those random awakening spells.
  • They seem to be very safe and well tolerated in most patients.
  • Very promisingly, they are very effective for patients with dementia and Alzheimer’s disease. This is a significant breakthrough because, as we noted, insomnia is a major health risk for our older adults, and this is a population where traditional hypnotics are often contraindicated.

• Disadvantages:

• • A major drawback to this class of medication is the considerable cost. All three are still brand-name only and can be quite expensive. Often, insurance companies require a prior authorization or may decline to cover them as a first-line option. They may want you to try something older and more affordable first. Hopefully, these will become more accessible first-line options as they become more affordable over time.

Melatonin and Melatonin Agonists

Finally, we have our melatonin and melatonin agonist medications.

• Melatonin (Supplement): Most of us are aware of what melatonin is, but to review, it’s an endogenous hormone released by the pineal gland in response to darkness, and this helps cue the brain to go to sleep.

• • There are many melatonin supplements available, and many patients are willing to try these before moving on to prescription medications.
  • Based on my review of the literature, the most widely recommended dosage was between 1 and 3 milligrams. We want to keep it on the lower end, as higher doses are not necessarily more effective and may cause more side effects.
  • It’s important to administer it correctly: 1 to 2 hours before bedtime. A lot of patients make the mistake of taking it right when they get into bed, but it’s not a sedative; it’s a timer. It needs time to work on the brain’s internal clock.
  • For those with delayed sleep phase disorders (e.g., “night owls” who naturally fall asleep very late and wake up late), you actually want to administer it up to 6 hours before their desired bedtime to help shift their circadian rhythm earlier.

• Ramelteon (Rozerem): This is a prescription melatonin agonist that comes in one dose of 8 milligrams. It agonizes two specific melatonin receptors (MT1 and MT2), which is why we believe it works well for sleep issues.
• Primary Use and Advantages:

• • Both the melatonin supplement and the prescription agonist, ramelteon, are best for those with issues with falling asleep (sleep onset) or those who have experienced a disruption in their circadian rhythm, for example, from shift work or from jet lag.
  • Most studies I found recommended these options for minors because of the low risks associated with them, including no risk for dependency or tolerance. Ramelteon is not a controlled substance.
  • Melatonin supplements are widely available.

• Disadvantages and Cautions:

• • When choosing a supplement, we recommend selecting a high-quality, trusted brand that has high standards for quality assurance (e.g., one with a USP or NSF certification).
  • Even with that, it’s important to remember that the FDA does not regulate supplements in the same way as prescription drugs. There may be risks that the patient is not receiving the dose they believe they’re getting, or that the supplements are contaminated with other ingredients. Studies have found wide variability in the actual melatonin content of commercial products.

Case Study 1: M.C. – Navigating Insomnia with a History of Addiction

To bring these principles into a real-world context, let’s consider the case of M.C., a 57-year-old male patient. His story is one that we encounter frequently in our clinic, highlighting the intricate web of physical and mental health.

Patient Profile: M.C.

• Age: 57-year-old male
• Medical History:

• • Depression
  • Anxiety
  • Hypertension (high blood pressure)
  • Obesity
  • Alcohol Use Disorder (in recovery, sober for over 15 years)

• Current Status: M.C. is highly committed to his health. He is consistently adherent to his medication regimen for his chronic conditions and regularly attends both AA meetings and individual therapy. He reports that his depressive and anxious symptoms are well-managed and mostly absent.
• Chief Complaint: His primary struggle is insomnia. For the past several months, he has had difficulty sleeping on more than half the days of the week. He experiences both sleep-onset insomnia (trouble falling asleep) and sleep-maintenance insomnia (trouble staying asleep). He has tried over-the-counter melatonin without success and is justifiably worried about trying any controlled substance due to his history of addiction.

This case requires a thoughtful, multi-layered approach that respects his history, addresses his current symptoms, and prioritizes his long-term safety and well-being.

Crafting a Treatment Plan: A Step-by-Step Assessment

When a patient like M.C. presents to our clinic, our first step is a comprehensive assessment. This goes far beyond just his sleep complaint. We need to understand the full context of his life and health. Under the collaborative guidance of Dr. Cardenas and myself, we formulate a plan that integrates medical, functional, and lifestyle considerations.

1. Deep Dive into Sleep Hygiene and Practices

Before considering any medication, we must first scrutinize his sleep hygiene. This is the foundation of good sleep. I would sit down with M.C. and have a detailed conversation about his daily routines and nighttime habits.

• What does his evening routine look like? Does he wind down, or is he engaged in stimulating activities like working on a computer, exercising intensely, or having stressful conversations close to bedtime?
• What is his sleep environment like? Is his bedroom dark, quiet, and cool? Is the bed used only for sleep and intimacy, or is it a place for work, eating, and watching TV?
• What are his dietary habits? Does he consume caffeine or large meals late in the evening? Alcohol, although he is sober, is a common disruptor we discuss with all patients, as it can fragment sleep in the second half of the night.
• Is he a “clock-watcher”? Many people with insomnia develop a habit of anxiously watching the clock, which only increases stress and makes sleep more elusive.

The goal here is to identify any problematic behaviors or environmental factors that could be sabotaging his sleep. Often, simple, targeted changes can make a profound difference, empowering the patient with tools they can control.

2. Assessing the Consequences of Insomnia

Next, we need to understand the impact of his poor sleep on his daytime functioning. Insomnia is not just a nighttime problem; it casts a long shadow over the following day.

• Next-Day Drowsiness: How tired does he feel during the day? Does he experience overwhelming sleepiness while driving, in meetings, or during quiet moments? This is a critical safety issue.
• Cognitive Impairment: Is he noticing problems with concentration, memory, or decision-making?
• Mood and Irritability: Does a poor night’s sleep affect his mood, making him more irritable or emotionally fragile?

Understanding these consequences helps us gauge the severity of the problem and underscores the urgency of finding an effective solution.

3. Evaluating Comorbidities and Risk Factors

M.C.’s medical history provides crucial clues. His age (over 50) and obesity are significant risk factors for a common and often undiagnosed condition: obstructive sleep apnea (OSA).

• What is Sleep Apnea? OSA is a sleep disorder where breathing repeatedly stops and starts. The airway collapses, leading to drops in blood oxygen levels and brief awakenings throughout the night. The person is often unaware of these awakenings but suffers from fragmented, non-restorative sleep.
• Symptoms to Screen For: We would ask M.C. about classic OSA symptoms:

• • Loud, disruptive snoring
  • Witnessed pauses in breathing during sleep (often reported by a bed partner)
  • Waking up choking or gasping for air
  • Morning headaches
  • Excessive daytime sleepiness despite a full night in bed

Given his risk profile, it is imperative to consider this possibility. If we have a high index of suspicion, the most appropriate step would be to refer him for a formal sleep study (polysomnography) with a sleep medicine specialist. Treating his insomnia with sleep aids without addressing potential underlying sleep apnea could be ineffective and even dangerous, as some hypnotics can worsen respiratory depression.

Integrating Chiropractic and Functional Medicine Perspectives

This is where our unique multidisciplinary approach at Injury Medical Clinic becomes so valuable.

The Chiropractic Connection: Structural and Neurological Integrity

From a chiropractic perspective, I would assess M.C. for any vertebral subluxations, particularly in the cervical (neck) and upper thoracic (mid-back) regions. Misalignments in the spine can interfere with the autonomic nervous system (ANS), which regulates our “fight-or-flight” (sympathetic) and “rest-and-digest” (parasympathetic) responses.

• Autonomic Nervous System Imbalance: Chronic stress, poor posture, or physical trauma can lead to a state of sympathetic dominance. This means the body is stuck in a hyper-aroused, “on-alert” state, which is antithetical to restful sleep. The brain and body are constantly being told there is a threat, making it incredibly difficult to relax and fall asleep.
• Chiropractic Adjustments: By performing specific, gentle chiropractic adjustments, we can help restore proper spinal mechanics and reduce nerve interference. This can help down-regulate the sympathetic nervous system and promote a shift toward a more parasympathetic state, which is essential for relaxation and sleep onset. Many of my patients report an immediate sense of calm and improved sleep quality following an adjustment.
• Soft Tissue and Rehabilitation: We would also address any muscular tension in his neck and shoulders, which is a common physical manifestation of stress and can contribute to discomfort that interferes with sleep. Techniques like massage therapy, myofascial release, and stretching protocols can be highly effective.

The Functional Medicine Lens: Digging for Root Causes

A functional medicine workup would look even deeper into the biochemical and physiological underpinnings of his insomnia.

• Hormonal Imbalances: We would consider testing his cortisol rhythm using a 4-point salivary cortisol test. Normally, cortisol is high in the morning to help us wake up and gradually declines throughout the day, reaching its lowest point at night to allow for sleep. In many people with chronic stress and insomnia, this rhythm is disrupted. They may have low morning cortisol (leading to fatigue) and high evening cortisol (leading to a “tired but wired” feeling at bedtime).
• Nutrient Deficiencies: We would assess for potential deficiencies in key nutrients involved in sleep regulation, such as magnesium, B vitamins (especially B6), and vitamin D. Magnesium, for example, is a natural muscle relaxant and plays a role in calming the nervous system by supporting the function of GABA, our primary inhibitory neurotransmitter.
• Gut-Brain Axis: There is a powerful connection between gut health and brain function, including sleep. An imbalance in the gut microbiome (dysbiosis) or underlying gut inflammation can send inflammatory signals to the brain, disrupting neurotransmitter production and sleep architecture. A comprehensive stool analysis could provide valuable insights.
• Inflammation: C.’s obesity and hypertension are indicative of a pro-inflammatory state. Chronic, low-grade inflammation can disrupt sleep by altering the production of sleep-regulating cytokines. We would look at inflammatory markers like C-reactive protein (CRP) and implement an anti-inflammatory diet and lifestyle plan.

By integrating these perspectives, we move from simply treating the symptom (insomnia) to addressing the underlying dysfunctions in his nervous system, hormonal pathways, and metabolic health.

Formulating a Pharmacological and Behavioral Strategy

Once we have a complete picture, we can formulate a treatment plan that incorporates all these elements. Given M.C.’s history of addiction, our approach to medication must be exceptionally cautious. His own reluctance to use controlled substances is a great asset and aligns perfectly with best practices.

Prioritizing Low-Risk Medications

Under the medical direction of Dr. Cardenas, we have several excellent non-controlled or low-risk pharmacological options to consider.

• Doxepin (Silenor): This is a tricyclic antidepressant, but at very low doses (3-6 mg), it acts as a highly selective histamine H1 receptor antagonist. It does not have the typical antidepressant effects at this dose. Its primary function is to block histamine, a wake-promoting neurotransmitter, thereby helping with sleep maintenance. It has a very low risk of dependency and is not a controlled substance, making it an excellent first-line choice for a patient like M.C.
• Ramelteon (Rozerem): This is a melatonin receptor agonist. It works by binding to the MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus (the body’s master clock), the same receptors that our own melatonin uses. It helps regulate the sleep-wake cycle and is primarily effective for sleep-onset insomnia. Like doxepin, it is not a controlled substance and has no potential for abuse or dependency.
• Dual Orexin Receptor Antagonists (DORAs): This newer class of medications includes drugs like suvorexant (Belsomra), lemborexant (Dayvigo), and daridorexant (Quviviq). They work by a novel mechanism: blocking orexin, a key wake-promoting neurotransmitter. Instead of “forcing” the brain to sleep (like benzodiazepines), they “turn off the wake signal.” While they are classified as Schedule IV controlled substances, their potential for abuse, tolerance, and dependency is considered significantly lower than that of the benzodiazepines and Z-drugs (Rosenberg, Schweitzer, & Kirisoglu, 2023). For a patient with a history of addiction who needs help with both sleep onset and maintenance, a DORA could be a very reasonable option after discussing the risks and benefits.

The Treatment Decision

M.C.’s insomnia involves both onset and maintenance issues. Therefore, we need a medication that can address both.

• A DORA like daridorexant would be a strong candidate because it has been shown to improve both falling asleep and staying asleep, with a favorable safety profile.
• Alternatively, we could consider a combination approach, such as Ramelteon for sleep onset, possibly combined with low-dose Doxepin for sleep maintenance, though we generally prefer to start with monotherapy.

The final decision would be made through a process of shared decision-making. I would present these options to M.C., explaining the mechanism of action, potential side effects, and risk profile of each. His preference is paramount. His desire to avoid anything that might trigger his past addiction is a guiding principle, and we would honor that.

Putting It All Together: The Integrative Plan for M.C.

1. Medical Oversight (Dr. Cardenas):

• • Prescribe the chosen low-risk hypnotic (e.g., Daridorexant or Doxepin).
  • Manage his hypertension and other medical comorbidities.
  • Order a referral to a sleep specialist to rule out sleep apnea.

• Chiropractic and Rehabilitative Care (Dr. Jimenez):

• • Perform regular chiropractic adjustments to improve autonomic nervous system balance.
  • Implement soft tissue therapy and stretching to reduce musculoskeletal tension.
  • Provide ergonomic and postural education.

• Functional Medicine Interventions (Dr. Jimenez):

• • Implement a comprehensive sleep hygiene education
  • Recommend an anti-inflammatory, whole-foods-based diet to support weight management and reduce inflammation.
  • Suggest targeted nutritional supplements based on lab testing (e.g., magnesium glycinate, vitamin D).
  • Consider a 4-point cortisol test to assess his stress-response axis.

• Behavioral Support:

• • Encourage continued engagement with his therapist, perhaps with a new focus on Cognitive Behavioral Therapy for Insomnia (CBT-I), the gold standard non-pharmacological treatment.
  • Reinforce his commitment to his AA program.

This comprehensive, collaborative plan addresses M.C. from every angle—pharmacologically, structurally, biochemically, and behaviorally. It respects his history, empowers him with knowledge and tools, and provides a safe and effective path toward restoring restful sleep.

Case Study 2: C.P. – The Complexity of Insomnia in an Older Adult

Now, let’s turn our attention to a more complex and vulnerable patient, C.P. Her case illustrates the challenges and critical safety considerations involved in managing insomnia in the geriatric population.

Patient Profile: C.P.

• Age: 70-year-old female
• Chief Complaint: Chronic insomnia. She has been taking zolpidem (Ambien) 5 mg for ten weeks, and she reports it is no longer working effectively.
• Sleep Pattern: While she can still fall asleep without issue, she now awakens around 3-4 hours later and has great difficulty falling back asleep. This is a classic case of sleep-maintenance insomnia.
• Daytime Symptoms: She is now finding it difficult to avoid napping for 2-3 hours during the day, which is likely disrupting her nighttime sleep drive.
• Comorbidities:

• • Mild Cognitive Impairment (MCI): A condition involving noticeable declines in memory and thinking skills, which can be a precursor to dementia.
  • Recurrent Depression: A history of mood disorders.
  • Atopic Dermatitis (Eczema): She reports her eczema has worsened recently, and the associated itching (pruritus) makes it difficult for her to rest comfortably.
  • Osteoporosis: A condition where bones become weak and brittle, increasing the risk of fractures from falls.

• Problematic Sleep-Related Behaviors: She admits to often watching television in bed when she can’t sleep and taking long daytime naps.

C.P.’s case is a clinical minefield. We have an older adult with cognitive impairment and a high fall risk (due to age and osteoporosis) who is on a medication (zolpidem) known to increase these risks. Poor sleep hygiene, a painful skin condition, and a potential recurrence of depression complicate her insomnia.

Deconstructing the Problem: A Safety-First Approach

With a patient like C.P., my primary directive is primum non nocere—first, do no harm. Every decision must be filtered through the lens of safety, especially given her age, MCI, and osteoporosis.

The Problem with Zolpidem (and other “Z-drugs”)

Zolpidem belongs to a class of drugs called non-benzodiazepine hypnotics, often referred to as “Z-drugs” (zolpidem, zaleplon, eszopiclone). While they were initially marketed as being safer than older benzodiazepines, we now know they carry significant risks, particularly in older adults (Sateia, Buysse, Krystal, & Neubauer, 2017).

• Mechanism of Action: They work by enhancing the effect of the neurotransmitter GABA at a specific subtype of the GABA-A receptor. This slows down brain activity, inducing sleep.
• Risks in Older Adults:

• • Increased Fall Risk: They can cause next-day drowsiness, dizziness, and impaired coordination, significantly increasing the risk of falls and fractures. For C.P., who has osteoporosis, a fall could be catastrophic.
  • Cognitive Impairment: Z-drugs can worsen memory and concentration, which is especially concerning in a patient who already has MCI. There is ongoing research into a potential association between long-term use and an increased risk of dementia.
  • Complex Sleep-Related Behaviors: These medications carry a black box warning for behaviors like sleepwalking, sleep-driving, and sleep-eating, during which the person is not fully awake and has no memory of the event.
  • Tolerance and Rebound Insomnia: As C.P. is experiencing, tolerance can develop quickly, meaning the drug stops working at the original dose. Stopping the drug abruptly can lead to rebound insomnia, where sleep becomes even worse than before.

To Increase the Dose or to Switch? A Critical Decision

C.P. reports her zolpidem 5 mg is no longer effective. A common, but often risky, impulse would be to increase the dose to 10 mg. For C.P., this would be a poor choice. The FDA has specifically recommended a lower starting dose (5 mg for immediate-release) for women and older adults due to slower drug metabolism, which can lead to higher blood levels and increased risk of next-day impairment. Increasing her dose to 10 mg would amplify all the risks mentioned above.

A slightly better, but still cautious, option might be to switch her to the controlled-release formulation, zolpidem CR 6.25 mg. This formulation is designed to help with sleep maintenance. While it represents a small increase in the total dose, its release profile might better match her needs.

However, the safest and most evidence-based approach would be to switch her to a medication with a better safety profile.

The Best Choice: Switching to a Dual Orexin Receptor Antagonist (DORA)

Given C.P.’s specific risk factors, a DORA (like suvorexant, lemborexant, or daridorexant) emerges as a superior choice.

• Safer Overall Profile: As discussed previously, DORAs work by blocking wakefulness rather than inducing sedation through GABA. This mechanism is associated with a lower risk of cognitive impairment, motor incoordination, and falls compared to Z-drugs and benzodiazepines (Neubauer, 2022).
• Efficacy in Cognitive Impairment: Studies have shown that DORAs, particularly lemborexant, can be effective in patients with cognitive impairment and even Alzheimer’s disease, without worsening cognitive function. This makes them an ideal choice for C.P.
• Effectiveness for Sleep Maintenance: DORAs are effective for both sleep onset and, crucially for C.P., sleep maintenance.

Therefore, under Dr. Cardenas’s medical supervision, a carefully managed cross-taper from zolpidem to a low dose of a DORA would be the most prudent pharmacological strategy. This involves gradually decreasing the zolpidem dose while slowly introducing the new medication to minimize withdrawal effects and rebound insomnia.

The Integrative and Behavioral Imperative

Medication is only one piece of the puzzle for C.P. Her behavioral patterns and untreated comorbidities are significant contributors to her insomnia. A truly effective plan must address these head-on.

1. Aggressive Sleep Hygiene Intervention

C.P. has two glaringly poor sleep habits that must be corrected. This requires compassionate but firm education and counseling.

• Eliminating Long Daytime Naps: Her 2-3 hour naps are severely eroding her “sleep drive” or “sleep pressure” that builds up during wakefulness. This makes it much harder to sleep through the night. We would advise her to eliminate naps, or if necessary, to limit them to a single 20-30 minute “power nap” before 3 p.m.
• Getting Out of Bed: Her habit of watching television in bed when she can’t sleep is counterproductive. It trains the brain to associate the bed with wakefulness and arousal. We would teach her the “15-Minute Rule” of CBT-I: If she is awake in bed for more than 15-20 minutes, she should get out of bed, go to another room, and do something quiet and relaxing (like reading a book under dim light, listening to calm music, or meditating). She should only return to bed when she feels sleepy again. This helps re-establish the powerful mental connection between the bed and sleep.

2. Addressing the Itch: The Somatosensory Connection

C.P.’s disclosure that her worsening eczema is impairing her ability to rest is a critical piece of information. The constant itching creates a state of physical discomfort and agitation that is physiologically incompatible with sleep. This must be addressed.

• Medical Management: As part of our collaborative care model, this issue requires immediate attention. If it is within my scope as an FNP, I might prescribe topical corticosteroids or other anti-inflammatory creams. However, given the severity and its impact on her quality of life, the best course of action would be to refer her to a dermatologist. An allergist might also be consulted to identify potential triggers. Dr. Cardenas would facilitate this referral to ensure her skin condition is optimally managed.
• Chiropractic and Somatic Support: From a chiropractic standpoint, chronic discomfort and inflammation can heighten nervous system sensitivity. Gentle adjustments can help calm the nervous system. Additionally, we can teach her relaxation techniques like progressive muscle relaxation or mindfulness meditation to help her cope with the physical sensation of itching without becoming overwhelmed.

3. Re-evaluating Her Mood

Given her history of recurrent depression, it is essential to screen her for a current depressive episode. Worsening depression is a common cause of sleep-maintenance insomnia, often characterized by early morning awakenings.

• Screening Tools: We would use standardized screening tools like the PHQ-9 (Patient Health Questionnaire-9) to assess the severity of any depressive symptoms.
• Collaboration with Mental Health: We would ask about her current mental health support. Is she seeing a therapist? Is she on an antidepressant, and is it still effective? If her depression appears to be poorly controlled, we would need to address it directly, either by adjusting her medication (in collaboration with her psychiatrist or primary care provider) or referring her to a mental health specialist. Untreated depression will make it nearly impossible to resolve her insomnia.

The Integrated Care Plan for C.P.

1. Pharmacological Management (Dr. Cardenas):

• • Initiate a gradual cross-taper from zolpidem to a low-dose DORA (e.g., lemborexant 5 mg or daridorexant 25 mg), prioritizing her safety.
  • Monitor for any adverse effects and adjust the dose as needed.

• Comorbidity Management:

• • Refer her to a dermatologist to aggressively treat her atopic dermatitis.
  • Screen for depression and collaborate with her mental health provider to ensure her mood is stable.
  • Continue management of her osteoporosis, emphasizing fall prevention strategies.

• Behavioral and Lifestyle Interventions (Dr. Jimenez & Team):

• • Provide intensive education on sleep hygiene, focusing on eliminating daytime naps and getting out of bed when awake.
  • Strongly recommend and facilitate a referral for Cognitive Behavioral Therapy for Insomnia (CBT-I), which is highly effective in older adults.
  • Teach relaxation techniques to manage both stress and physical discomfort from her eczema.

• Chiropractic and Physical Rehabilitation:

• • Perform gentle chiropractic adjustments to promote nervous system regulation and reduce physical stress.
  • Incorporate balance and strength training into her rehabilitation plan to mitigate her fall risk associated with age and osteoporosis.

This case powerfully demonstrates that managing insomnia in a complex patient is not about finding the right “sleeping pill.” It is about meticulous detective work, prioritizing safety, and building a comprehensive, team-based plan that addresses every contributing factor.

Core Principles for Effective Insomnia Management

Across all patients, from the relatively straightforward to the highly complex, a set of core principles should guide our approach to managing insomnia. These principles are centered on patient empowerment, personalization, and safety.

Embrace Shared Decision-Making

The era of paternalistic medicine, where the provider dictates a treatment plan, is over. The most effective and sustainable outcomes are achieved through shared decision-making. This means I see my role not as an authority figure, but as an expert guide who partners with the patient.

• The Process: This involves a collaborative conversation where I:

1. 1. Clearly explain the patient’s condition and the underlying physiology.
   2. Present all reasonable treatment options, including the “option” of doing nothing.
   3. Thoroughly discuss the potential benefits, risks, side effects, and costs of each option.
   4. Elicit the patient’s values, preferences, and goals. What is most important to them?
   5. Make a decision together.

When a patient is actively involved in creating their treatment plan, they feel a sense of ownership. This dramatically increases their buy-in and adherence, whether it’s taking a medication as prescribed or committing to challenging behavioral changes.

Individualize the Treatment Plan

There is no “one-size-fits-all” algorithm for insomnia. Every treatment plan must be tailored to the individual’s unique characteristics.

1. Target the Specific Sleep Disturbance

It’s crucial to know what kind of insomnia the patient has.

• Sleep-Onset Insomnia (Trouble falling asleep): This calls for a medication with a rapid onset and relatively short half-life, so it doesn’t cause excessive morning grogginess. Ramelteon or Zaleplon are classic examples.
• Sleep-Maintenance Insomnia (Trouble staying asleep): This requires a medication with a longer duration of action to last through the night. Low-dose doxepin, DORAs, or controlled-release formulations of Z-drugs are designed for this purpose.
• Mixed Insomnia (Both onset and maintenance): This is very common and requires a versatile medication that can do both, such as the DORAs or eszopiclone.

2. Modify Based on Age and Gender

• Older Adults: As we saw with C.P., the principle is “start low, go slow.” We must prioritize lower-risk medications like doxepin, ramelteon, and the DORAs. We should avoid benzodiazepines and use Z-drugs with extreme caution, if at all. Fall prevention is a paramount concern.
• Female Patients: Women often metabolize certain drugs, particularly zolpidem, more slowly than men. This can lead to higher blood levels and an increased risk of next-day impairment. The FDA recommends starting with a lower dose for women.

3. Address Medical and Mental Comorbidities

We cannot treat insomnia in a vacuum. As we’ve seen, untreated conditions can perpetuate a cycle of poor sleep.

• Pain: Chronic pain from arthritis, fibromyalgia, or an injury is a major sleep disruptor.
• Nocturia: Frequent nighttime urination, often due to an enlarged prostate or overactive bladder, fragments sleep.
• Restless Legs Syndrome (RLS): An irresistible urge to move the legs, especially in the evening.
• Depression and Anxiety: These conditions are bidirectionally linked with insomnia. Poor sleep worsens mood, and poor mood worsens sleep.

A comprehensive plan involves actively managing these comorbidities to reduce their impact on sleep quality. Our integrative clinic model is perfectly suited for this, as we can address musculoskeletal pain with chiropractic care, manage medical issues with Dr. Cardenas, and address the functional/metabolic drivers of inflammation and hormonal imbalance.

4. Respect Patient Preferences

We must listen to our patients. If a patient like M.C. has a strong preference to avoid controlled substances, we must honor that and explore all other options first. If a patient is hesitant about medication and wants to focus on lifestyle changes, we should support and guide them in that effort. Ignoring a patient’s preferences is a sure way to ensure non-adherence.

5. Weigh the Risks and Benefits

Every intervention, whether it’s a pill or a lifestyle change, has a risk/benefit ratio. This calculation must be made for each patient. For a young, healthy adult with short-term insomnia, the risks of a short course of a Z-drug might be low. For an older adult with cognitive impairment and a fall risk like C.P., the same medication carries an unacceptably high risk. Our primary responsibility is to keep our patients safe while effectively promoting restful sleep.

Troubleshooting: When the First Treatment Doesn’t Work

Despite our best efforts, sometimes the initial treatment plan fails. What do we do then? A systematic approach is required.

Step 1: Increase the Dose

The first logical step is to increase the dose of the current medication gradually, provided it is safe to do so and we remain within the recommended dosage range. For example, if a patient started on daridorexant 25 mg and it’s well-tolerated but not fully effective, we might increase it to 50 mg.

Step 2: Switch to a Different Mechanism of Action

If dose escalation fails or is not possible, the next step is to switch to a hypnotic from a different class, one that works via a different neurochemical pathway.

• Example: If a patient tried low-dose doxepin (a histamine antagonist) and it didn’t help, it makes little sense to switch them to another antihistamine like hydroxyzine. Instead, we should pivot to a completely different mechanism. We might consider a DORA (orexin antagonist), a melatonin agonist (ramelteon), or, with caution, a GABA-ergic agent (like a Z-drug). This approach increases the probability of finding a pathway that the patient’s brain chemistry will respond to.

Step 3: Refer and Consult

If you have tried multiple evidence-based options and the patient’s insomnia remains resistant to treatment, it is time to seek help.

• Refer to a Specialist: The best course of action is to refer the patient to a board-certified sleep medicine specialist or a psychiatrist with expertise in sleep disorders. These specialists have advanced training and access to more sophisticated diagnostic tools and treatment strategies.
• Re-evaluate for Underlying Disorders: A persistent, treatment-resistant insomnia should raise a red flag. We must reconsider the possibility of an undiagnosed underlying condition, such as a more obscure sleep disorder like idiopathic hypersomnia or a complex psychiatric or medical illness. A sleep specialist is best equipped to conduct this advanced diagnostic workup.

Long-Term Management and the Art of Psychopharmacology

Managing chronic insomnia is a marathon, not a sprint. It requires ongoing monitoring, education, and a willingness to adapt the treatment plan over time.

Ongoing Monitoring and Education

• Tolerance and Abuse: For patients on controlled substances like Z-drugs or benzodiazepines, we must remain vigilant for signs of tolerance (needing more of the drug to get the same effect) or abuse (using the medication in a way other than prescribed). Regular follow-ups and, in some jurisdictions, urine drug screens and prescription monitoring program checks are part of responsible prescribing.
• Reinforce Sleep Hygiene: Behavioral change is hard. Patients often revert to old habits. At every follow-up visit, I make it a point to review sleep hygiene principles briefly. This repetition is key to helping them internalize and maintain these crucial lifestyle changes.
• Continue to Recommend CBT-I: Cognitive Behavioral Therapy for Insomnia (CBT-I) remains our best, most durable first-line treatment for chronic insomnia (Edinger et al., 2021). Even if a patient is on medication, CBT-I can help them develop coping skills, reduce sleep-related anxiety, and potentially lower their need for medication over the long term. If it is feasible and the patient can afford it, I will continue to recommend and refer for CBT-I.

Discontinuing Sleep Aids

At some point, the goal may be to discontinue the sleep medication. With few exceptions, this should always be done with a gradual taper.

• Formulate a Tapering Plan: I work with the patient to create a slow, step-by-step plan to reduce their dose over several weeks or even months. This minimizes the risk of withdrawal symptoms and rebound insomnia.
• The Exception: Severe Adverse Reactions: The only time we would stop a medication abruptly is in the case of a severe adverse reaction, such as a complex sleep-related behavior (e.g., sleep-driving) or a sudden onset of confusion or delirium. In these situations, safety dictates immediate cessation.

The Challenge of Treatment-Resistant Insomnia

Unfortunately, even after following all these guidelines, a small subset of patients will still not experience significant improvement. Their sleep remains poor, and their quality of life suffers. This is where we enter the realm of treatment-resistant insomnia.

My review of the literature reveals a frustrating reality: there are very few clear, evidence-based guidelines for managing this challenging condition. This is where the “art” of medicine and psychopharmacology comes into play, moving beyond rigid protocols and into a more nuanced, creative space.

Considering Polypharmacy

In these difficult cases, polypharmacy—the use of more than one hypnotic medication—may be indicated. The key is to combine two agents with different mechanisms of action to achieve a synergistic effect.

• Example Combinations:

• • A melatonin agonist (ramelteon) for sleep onset + a DORA (lemborexant) for sleep maintenance.
  • Low-dose doxepin (histamine antagonist) + a low-dose Z-drug (GABA-ergic agent).
  • A sedating antidepressant like trazodone + a DORA.

This is an advanced strategy that should only be undertaken by a practitioner with extensive education and training in sleep medicine and psychopharmacology, such as a psychiatrist or a sleep specialist. The risk of side effects, drug interactions, and additive sedation is high and requires expert management.

The Therapeutic Alliance

When navigating high-risk treatment options like polypharmacy, the relationship between the provider and the patient is paramount. A strong therapeutic alliance, built on trust, open communication, and mutual respect, is the foundation. The patient must feel safe reporting side effects, expressing concerns, and being an active partner in the process. This strong groundwork ensures that both parties are on the same page and can navigate the complexities of treatment together.

The Ultimate Strength: Interprofessional Collaboration

When in doubt, and especially when faced with a difficult-to-treat case, collaboration is our greatest strength. Siloed care is ineffective care.

Imagine a team-based approach for a patient with treatment-resistant insomnia:

• The Primary Care Provider (or Internist like Dr. Cardenas) manages the patient’s overall medical health and coordinates care.
• The Chiropractor (like myself) addresses structural and neurological imbalances contributing to a state of hyper-arousal.
• The Functional Medicine Practitioner (also myself) investigates and treats underlying metabolic, hormonal, and inflammatory drivers.
• The Sleep Medicine Specialist conducts advanced diagnostics and provides expert pharmacological recommendations.
• The Mental Health Provider/Therapist delivers CBT-I and addresses comorbid anxiety or depression.

When this team can collaborate and communicate effectively—sharing notes, holding case conferences, and working together to formulate a unified plan—the likelihood of a positive outcome increases exponentially. This is the model we strive for at Injury Medical Clinic. By breaking down the barriers between disciplines, we can work together as a cohesive unit to address the multifaceted nature of chronic insomnia and offer our patients the most comprehensive and hopeful path toward healing and restful nights.

SEO Tags: Insomnia, Sleep Disorders, Dr. Alex Jimenez, Chiropractic Care, Integrative Medicine, Functional Medicine, Dr. Maria Cardenas, El Paso TX, Neurophysiology of Sleep, Circadian Rhythm, Glymphatic System, Neuroplasticity, CBT-I, Sleep Hygiene, Hypnotic Medications, Benzodiazepines, Orexin Antagonists, Melatonin Agonists, Mental Health, Depression, Anxiety, Traumatic Brain Injury, Chronic Pain, Holistic Healthcare, sleep deprivation, integrative chiropractic care, cognitive behavioral therapy for insomnia, melatonin, El Paso chiropractor, sleep and health, chronic disease, sleep apnea, dementia risk, personal injury, rehabilitation, Insomnia Treatment, Dual Orexin Receptor Antagonists, Doxepin, Ramelteon, Zolpidem Risks, Insomnia in Older Adults, Shared Decision-Making, Treatment-Resistant Insomnia, Interprofessional Collaboration, Chiropractic for Sleep, Dr. Maria Cardenas MD, Autonomic Nervous System, Cortisol Rhythm, Case Study Insomnia, Personalized Medicine, Polypharmacy for Sleep

References

• Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., & Kazmi, U. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262.
• Irwin, M. R., & Vitiello, M. V. (2019). Implications of sleep disturbance and inflammation for Alzheimer’s disease. The Lancet Neurology, 18(3), 296-306.
• Kaur, H., & Tadi, P. (2023). Physiology, Orexin. In StatPearls. StatPearls Publishing.
• Neubauer, D. N. (2022). Orexin receptor antagonists for the treatment of insomnia: A new role for a new class of drugs. Journal of Clinical Psychiatry, 83(6), 22f14697.
• Neubauer, D. N. (2022). Pharmacotherapy for insomnia in adults. Retrieved July 20, 2026, from https://www.uptodate.com/contents/pharmacotherapy-for-insomnia-in-adults
• Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D. (2016). Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine, 165(2), 125–133.
• Rosenberg, R., Schweitzer, P. K., & Kirisoglu, C. (2023). The pharmacology of dual orexin receptor antagonists for the treatment of insomnia. Psychopharmacology, 240(9), 1831–1846.
• Sateia, M. J., Buysse, D. J., Krystal, A. D., & Neubauer, D. N. (2017). Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine, 13(2), 307–349.
• Savage, K., Zick, S. M., & Ko, M. G. (2021). Passionflower in the treatment of anxiety and insomnia: A review of the evidence. Journal of Alternative and Complementary Medicine, 27(8), 643-650.
• Wick, K. (2022, November 8). Cognitive behavioral therapy instead of sleeping pills. Mayo Clinic.